Navigation Links
New Medication Management And Adherence App, MyMeds, Introduced For iPhone, Android, Web; Unites Consumers, Pharmacists, Caregivers, Physicians
Date:7/10/2013

MINNEAPOLIS, July 10, 2013 /PRNewswire/ -- MyMeds®  (www.my-meds.com), a new medication management and adherence app introduced for mobile (Apple iPhones, Android), PCs and tablets, has been introduced as the most secure, easy-to-use complete personal medication record (PMR) app available in the U.S.

Chosen as one of the two best medication adherence apps out of 160 reviewed in the Journal of American Pharmacists Association, MyMeds was created by board certified nephrologist Dr. Rajiv Shah so consumers can create, track and share medication records with their family, caregivers, doctors and pharmacists.  The goal: to reduce the $300 billion cost and devastating health consequences that result from patients' failures to take medication as prescribed.

Inspired by Dr. Shah's background in cognitive psychology and clinical medicine, MyMeds is the only medication adherence app that combines digital technology and human psychology. MyMeds uses proprietary WhyMeds™ technology to create subconscious memory associations between medication names and the reasons for taking the medications.  The MyMeds system includes a website application, mobile applications for Android & iPhone, data storage on a HIPAA-compliant cloud server and a medications database with more than 14,000 prescription and over-the-counter drugs, vitamins, herbal supplements and birth control. 

"At the core of MyMeds is a team approach to improving medication adherence – and ultimately, improving health – that unites pharmacists, caregivers, patients, relatives and physicians," says Dr. Shah.  MyMeds enables users to:

  • Invite their doctor, pharmacist or caregiver to view or edit their medication profile and share medication records with them by email, text or print-
    '/>"/>

SOURCE MyMeds
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
2. Failure to Take Medicine Linked to Unnecessary Hospital Visits, Especially for Medicare Patients Taking High Blood Pressure or High Cholesterol Medications
3. CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety
4. Community Pharmacists Take on Medication Non-Adherence to Improve Patient Health
5. MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets
6. Omnicell Repeats Best in KLAS Award for OmniRx Automated Medication Dispensing System
7. Talyst Announces New Automated Medication Packager
8. Obesity journal publishes new study on lorcaserin, a weight-loss medication recommended for approval by FDA advisory panel
9. CVS Caremark Research Identifies Positive Link Between Medication Adherence and Employee Productivity
10. China Health Resource Develops Revolutionary Migraine Medication
11. HarborPath Creates a Single Portal for Uninsured Individuals to Access HIV/AIDS Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014 Today, iHealth Lab Inc. announced ... Ventures, Ltd. for its first institutional round of funding. ... iHealth,s global reach, accelerate growth and innovation, and invest ... the investment, Xiaomi Ventures will join iHealth,s board of ... infrastructure and ecommerce. "We are very pleased ...
(Date:9/19/2014)... , September 19, 2014 ... ) has announced the addition of the ... report to their offering.      ... have been broadly classified into wide categories ... used for the treatment of different gynecological ...
(Date:9/19/2014)... , Sept. 19, 2014  The board of ... declared a quarterly cash dividend of $0.42 per share.  ... 17, 2014 to stockholders of record at the close ... AbbVie AbbVie is a global, research-based biopharmaceutical company formed ... is to use its expertise, dedicated people and unique ...
Breaking Medicine Technology:iHealth Raises $25 Million to Fuel Growth and Global Market Share 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 3
... Calif., April 14 Researchers at,the Barbara ... been studying,racial disparities related to cancer patients. ... (AACR) Annual Meeting, Karmanos researchers,Vitaly Balan, Ph.D., ... their abstract, Galectin-3 nsSNP rs4644 Foretells Human ...
... 14 Perrigo Company,(Nasdaq: PRGO ; ... final approval,from the U.S. Food and Drug ... Cetirizine Hydrochloride Oral Solution,(Allergy) and Children,s Cetirizine ... will be marketed under store brand labels ...
Cached Medicine Technology:Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women 2Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women 3Perrigo Announces Approval for Over-the-Counter Children's Cetirizine Oral Solution 2
(Date:9/19/2014)... leading Dartmouth researcher, working with The Melanoma Genetics Consortium, ... today in the Journal of the National Cancer ... of melanoma. , "For the first time, we have ... telomeres play a part in the risk of developing ... PhD, School of Medicine at the University of Leeds ...
(Date:9/19/2014)... News) -- U.S. military troops deployed to sunny climates ... to a new study. Many returning troops ... some cases, military personnel developed blisters on their skin ... size of their moles since being deployed overseas. ... skin cancer, the study authors noted. "The past ...
(Date:9/19/2014)... The U.S. Food and Drug Administration approved a new type ... a class of once-a-week injectable drugs that help manage blood ... "Trulicity is a new treatment option, which can be used ... sugar levels in the overall management of type 2 diabetes," ... Drug Evaluation II, said in an agency news release. ...
(Date:9/19/2014)... 2014 MetroMD, a leading anti-ageing clinic has ... of human health. This therapy has grown tremendously across USA ... more effective, safe and dependable. It has far reaching benefits ... to live a very healthy and active lifestyle even beyond ... therapy, a senior therapist at MetroMD said, “HGH or Human ...
(Date:9/19/2014)... - New research published today in the online journal ... reach 6,800 in West Africa by the end of ... , Arizona State University and Harvard University researchers ... rise in cases significantly increased in August in Liberia ... was put in place, indicating that the mass quarantine ...
Breaking Medicine News(10 mins):Health News:Melanoma risk found to have genetic determinant 2Health News:Some U.S. Troops May Face Greater Skin Cancer Risk 2Health News:FDA Approves Another Weekly Injectable Drug for Type 2 Diabetes 2Health News:MetroMD Announces Better HGH Therapy - the ‘God Particle’ of Human Health 2Health News:Research predicts possible 6,800 new Ebola cases this month 2
... April 2010 - Elsevier, the world-leading publisher of ... proudly announces the release of a brand-new single ... mitral valve disease by the internationally renowned cardiac ... will launch at the 90th Annual Meeting of ...
... ... and printing products, today announced it is ready for immediate shipping of thousands of ... through customer service or instantly online from the company’s award winning web site My1Stop.com. ... Ft. Scott, ...
... ... money with FatWallet’s expert selection of deals for Mother’s Day. Experienced experts research the ... and seasonal categories such as laptops, HDTVs, Father’s Day and graduation. , ... (PRWEB) April 26, 2010 -- ...
... ... Documentation by Integrating Electronic Medical Forms Generated During the Pre-operative Process into Core ... ... important new level of clinical integration designed to provide immediate access to patient ...
... ... area residents safe and effective cosmetic and aesthetic treatments. Advanced Aesthetics utilizes top ... ... The art of aesthetics is continually changing. As technology progresses, innovative treatments replace ...
... that factors known to increase the risk of breast cancer ... Published early online in Cancer , a peer-reviewed journal ... is needed to evaluate how breast cancer risk factors differ ... frequently in certain ethnic and racial groups, but the reasons ...
Cached Medicine News:Health News:Elsevier launches Carpentier's reconstructive valve surgery book 2Health News:My1Stop.com New Packaging Supplies Offering for Distribution Centers and Small Business Shipping 2Health News:Expert Approved: FatWallet Guides Mother's Day Shoppers to the Best Deals Online 2Health News:SourceMedical Provides Ambulatory Surgery Centers with New Levels of Document Integration for Easy Access to Patient Data 2Health News:SourceMedical Provides Ambulatory Surgery Centers with New Levels of Document Integration for Easy Access to Patient Data 3Health News:In Coeur d'Alene Idaho, Top Of The Line Aesthetic Treatments And Non-Invasive Laser Technology Can Be Found Only At Advanced Aesthetics 2Health News:In Coeur d'Alene Idaho, Top Of The Line Aesthetic Treatments And Non-Invasive Laser Technology Can Be Found Only At Advanced Aesthetics 3Health News:Breast cancer risk factors differ among races 2
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
... provide a broad selection of ... a wide variety of ophthalmic ... is packaged sterile, complete with ... switch in the "off " ...
... provide a broad selection of ... a wide variety of ophthalmic ... is packaged sterile, complete with ... switch in the "off " ...
Medicine Products: